These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32329196)

  • 1. O-glycan initiation directs distinct biological pathways and controls epithelial differentiation.
    Bagdonaite I; Pallesen EM; Ye Z; Vakhrushev SY; Marinova IN; Nielsen MI; Kramer SH; Pedersen SF; Joshi HJ; Bennett EP; Dabelsteen S; Wandall HH
    EMBO Rep; 2020 Jun; 21(6):e48885. PubMed ID: 32329196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
    Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
    J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
    Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
    J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lavrsen K; Dabelsteen S; Vakhrushev SY; Levann AMR; Haue AD; Dylander A; Mandel U; Hansen L; Frödin M; Bennett EP; Wandall HH
    J Biol Chem; 2018 Jan; 293(4):1298-1314. PubMed ID: 29187600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line.
    Nielsen MI; de Haan N; Kightlinger W; Ye Z; Dabelsteen S; Li M; Jewett MC; Bagdonaite I; Vakhrushev SY; Wandall HH
    Nat Commun; 2022 Oct; 13(1):6257. PubMed ID: 36270990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.
    Schjoldager KT; Joshi HJ; Kong Y; Goth CK; King SL; Wandall HH; Bennett EP; Vakhrushev SY; Clausen H
    EMBO Rep; 2015 Dec; 16(12):1713-22. PubMed ID: 26566661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.
    Sheta R; Woo CM; Roux-Dalvai F; Fournier F; Bourassa S; Droit A; Bertozzi CR; Bachvarov D
    J Proteomics; 2016 Aug; 145():91-102. PubMed ID: 27095597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.
    Argüeso P; Tisdale A; Mandel U; Letko E; Foster CS; Gipson IK
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):86-92. PubMed ID: 12506059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus.
    Röttger S; White J; Wandall HH; Olivo JC; Stark A; Bennett EP; Whitehouse C; Berger EG; Clausen H; Nilsson T
    J Cell Sci; 1998 Jan; 111 ( Pt 1)():45-60. PubMed ID: 9394011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
    Kong Y; Joshi HJ; Schjoldager KT; Madsen TD; Gerken TA; Vester-Christensen MB; Wandall HH; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
    Glycobiology; 2015 Jan; 25(1):55-65. PubMed ID: 25155433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells.
    Raghu D; Mobley RJ; Shendy NAM; Perry CH; Abell AN
    Cell Rep; 2019 Mar; 26(13):3684-3697.e7. PubMed ID: 30917321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family.
    Mandel U; Hassan H; Therkildsen MH; Rygaard J; Jakobsen MH; Juhl BR; Dabelsteen E; Clausen H
    Glycobiology; 1999 Jan; 9(1):43-52. PubMed ID: 9884405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
    Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of
    Cejas RB; Lorenz V; Garay YC; Irazoqui FJ
    J Biol Chem; 2019 Mar; 294(9):2997-3011. PubMed ID: 30591584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Regulation of Protein O-Glycosylation in Isogenic Human HEK293 Cells by Differential O-Glycoproteomics.
    Narimatsu Y; Joshi HJ; Schjoldager KT; Hintze J; Halim A; Steentoft C; Nason R; Mandel U; Bennett EP; Clausen H; Vakhrushev SY
    Mol Cell Proteomics; 2019 Jul; 18(7):1396-1409. PubMed ID: 31040225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
    Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific
    Goth CK; Tuhkanen HE; Khan H; Lackman JJ; Wang S; Narimatsu Y; Hansen LH; Overall CM; Clausen H; Schjoldager KT; Petäjä-Repo UE
    J Biol Chem; 2017 Mar; 292(11):4714-4726. PubMed ID: 28167537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
    Wandall HH; Hassan H; Mirgorodskaya E; Kristensen AK; Roepstorff P; Bennett EP; Nielsen PA; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
    J Biol Chem; 1997 Sep; 272(38):23503-14. PubMed ID: 9295285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.